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Studies of the mammalian cell cycle in vivo have been hampered by the lack of pure populations of prolifer-
ating cells. In this issue ofDevelopmental Cell, Klochendler and colleagues (2012) develop a novel transgenic
mouse that expresses Cyclin B1-GFP ubiquitously. By sorting and analyzing proliferating hepatocytes, they
provide evidence for their transient dedifferentiation.For a long time, an important question for
cell biologists has been whether, or to
what degree, eukaryotic cells dedifferen-
tiate during cellular replication. While
much information about cell-cycle control
has been gained from the study of immor-
talized cell lines, these cells do not fully
represent terminally differentiated cells
that exist in tissues and are thus not a
good model to address this question.
Analyzing cycling cells in vivo has proven
to be difficult in the past for several
reasons. First, in continuously regenerat-
ing tissues such as skin and intestine,
rapidly cycling stem and progenitor cells
maintain tissue homeostasis but differen-
tiate only after exit from the cell cycle.
Second, even in tissues such as the liver,
in which massive, near-synchronous
reentry into the cell cycle of mature hepa-
tocytes can be triggered by surgical
removal of two-thirds of the organ, less
than half of hepatocytes enter the cell
cycle; thus, any biochemical and molec-
ular analysis of proliferating cells is
hampered by contamination of noncy-
cling cells.
In principle, this problem could be ap-
proached through the use of thymidine
analogs that are incorporated into cellular
DNA during replication, or S phase.
Indeed, these reagents have been used
successfully for decades for post hoc
analysis of proliferating cells in vivo and
have been very useful, for instance, in
the evaluation of the efficacy of various
mitogens and the analysis of animals
with mutations in cell-cycle regulators.
However, these reagents require the fixa-
tion of the tissue on subsequent immuno-676 Developmental Cell 23, October 16, 2012logical detection of the incorporated label.
Thus, the isolation and molecular analysis
of live proliferating cells from mammalian
tissues has proven to be challenging.
The study by Klochendler and col-
leagues (2012) in the current issue of
Developmental Cell provides an elegant
solution to the problem. The authors
reasoned that a fluorescent protein fused
to the so-called ‘‘destruction box’’ of
Cyclin B1 could be employed to mark
and sort cycling cells in vivo. This idea is
based on the discovery more than 10
years ago that the protein levels of Cyclin
B1 are controlled by ubiquitin-mediated
degradation, beginning in M phase of
the cell cycle (Sudakin et al., 1995).
Specifically, Klochendler and colleagues
employed a fusion protein of the first 105
amino acids of Cyclin B1, containing the
RXXL destruction box, with the jellyfish
green fluorescent protein (GFP), because
this chimeric molecule had been shown
tomimic the cell-cycle behavior of endog-
enous Cyclin B1 in cultured cells (Zur
and Brandeis, 2002). Because Cyclin
B1-GFP, just like endogenous Cyclin B1,
is synthesized de novo in S phase, in
these transgenic mice GFP is present in
cycling cells through S, G2, andM phases
of the cell cycle.
After careful validation of their new
transgenic model, Klochendler and
colleagues demonstrate its usefulness
by analyzing the gene expression profile
of cycling hepatocytes (Klochendler et al.,
2012). Because replication of hepato-
cytes in the uninjured liver of the adult
mammals is negligible, they used growing
livers of juvenile animals in which aboutª2012 Elsevier Inc.10% of hepatocytes are cycling. As ex-
pected, GFP-positive and thus cycling
hepatocytes expressedmany established
proliferation markers—such as Ki67 and
Cyclin B1 itself—at high levels, demon-
strating the validity of the new model. Of
particular interest is their finding that
a large set of ‘‘differentiation-associated’’
genes had reduced expression in cycling
hepatocytes. Among these are the genes
encoding enzymes involved in glycolysis,
lipid, and xenobiotic metabolism. This
observation confirms and extends a prior
gene expression profiling study in which
whole liver was analyzed at various time
points following partial hepatectomy
(White et al., 2005). It is clear, then, that
replicating hepatocytes undergo partial
transcriptional dedifferentiation.
A long-standing question has been to
what degree the dedifferentiation that
occurs in hepatocellular carcinoma is
tumor specific. Klochendler and col-
leagues suggest that this, in fact, is aprop-
erty of all cycling hepatocytes, whether
cancerous or not. In contrast, the gene
expression signature characteristic of
fetal cells, such as expression of the hep-
toblast marker alpha-feto protein, was not
seen in replicating normal hepatocytes,
whereas it is a common feature in liver
cancer. Thus, their comprehensive
profiling of dividing normal hepatocytes
has already identified important similari-
ties and differences to hepatocellular
carcinoma.
The transgenicmousemodel described
above is of course useful not only for the
study of proliferation in the liver, but also
of all cell types, because the authors
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Previewsemployed a ubiquitous promoter to drive
expression of the Cyclin B1-GFP fusion
protein. Thus, the application of sorting
of live, proliferating cells can now be
expanded to the rare replicating neuron,
just as it can be to the rapidly regenerating
intestinal epithelium. Future work could
also make use of intercrossing of the
current transgenic line with other trans-
genic mice expressing fluorescent pro-
teins with different excitation/emission
properties in cells of interest, thus allow-ing for dual-label sorting of replicating
cells from complex tissues. The novel
tool developed by Klochendler and
colleagues thus represents in a major
step forward in the analysis of prolifera-
tion of normal mammalian cells and
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Hedgehog signaling is transduced at the primary cilium, but the precise mechanisms underlying this action
are not clear. In this issue ofDevelopmental Cell, Dorn and colleagues (2012) describe a novel mechanism for
control of Hedgehog signaling by Evc proteins within the primary cilium.The Hedgehog (Hh) signaling pathway
has received enormous attention over
the years because it plays an essential
role in many aspects of vertebrate embry-
onic development and tumorigenesis (re-
viewed in Ingham et al., 2011). Despite
this focus, the biochemical steps leading
from ligand binding to target gene
activation are far from clear. Roughly
a decade ago, genetic experiments re-
vealed the requirement of the primary
cilium, a microtubule-based, membrane-
enclosed structure, for mammalian Hh
signaling. Subsequent work indicated
that this small yet nearly ubiquitous
‘‘organelle’’ represents a central process-
ing center where Hh signaling information
is transduced. Indeed, most of the
core factors regulating the pathway,
including a transmembrane activator lying
upstream in the pathway, Smoothened
(Smo), and the pathway effectors, the Gli
transcription factors, localize to primary
cilia in a manner gated by pathway
activity. Current models posit that acti-
vated Smo localizes to ciliary membranesin response to ligands, where it then
suppresses Protein Kinase A (PKA)-medi-
ated phosphorylation of the Gli proteins
and induces dissociation of Gli proteins
from their inhibitor, Suppressor of Fused
(SuFu). However, how each of these
events occurs at the biochemical level
within the cilium is unknown.
To begin to tackle this problem, Dorn
and colleagues (2012) have focused their
attention on the transmembrane protein
Evc2, which is mutated in two human
disorders, Ellis–van Creveld syndrome
(EvC) and Weyers acrodental dystosis
(Weyers) (Ruiz-Perez et al., 2000). EvC
and Weyers are classified as ‘‘ciliopa-
thies,’’ which encompass a spectrum of
related disorders caused by defective
ciliary structure or function. EvC is an
autosomal-recessive disorder in which
patients harbor loss-of-function muta-
tions in Evc2, the neighboring Evc2-inter-
acting protein Evc, or, in rare cases, both
proteins. Weyers is an autosomal-domi-
nant disorder with phenotypic character-
istics similar to EvC, and patients withthis disease harbor deletions in the C
terminus of Evc2. The fact that at least
some of the phenotypic features are
linked to dysregulation of the Hh pathway
led to previous studies showing that
mammalian Hh signaling requires Evc
proteins and that Evc and Evc2 localize
near the base of primary cilia (Blair et al.,
2011). Interestingly, the human and
mouse mutant phenotypes and evc
expression patterns suggest that this
requirement is tissue specific.
In the present work, Dorn et al. show
that Evc2, in a complex with Evc, physi-
cally associates with Smo in the cilium in
response to pathway activation. These
findings are backed up by similar results
from Jin Jiang and colleagues (Yang
et al., 2012). While Evc/Evc2 are required
for cilium-dependent Hh signaling, they
do not appear to control ciliary assembly
or structure. Epistasis analysis indicates
that these proteins act in the Hh pathway
at a step upstream of the Gli proteins and
the negative regulators SuFu and PKA.
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